Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide
Eric L Snyder, Bryan R Meade, Cheryl C Saenz et al. · 2004
Read Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide by Eric L Snyder, Bryan R Meade, Cheryl C Saenz et al. (2004) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pbio-0020036.txt.
Description
Eric L. Snyder, Bryan R. Meade, Cheryl C. Saenz, and co-workers tested a bold cancer treatment in PLOS Biology in 2004. Peritoneal carcinomatosis is cancer spread across the belly lining, often from ovarian cancer. It resists standard chemotherapy and has a grim outlook.
Their approach uses a peptide, a short protein chain, that can cross into cells and switch on p53. p53 is a guard protein that can push damaged cells to die. Turning it on inside spread tumor cells offers a way to attack the disease at many sites at once. The study is an early proof of concept. It points to cell-penetrating peptides as a delivery route worth refining.
Catalog record
| CREATOR | Eric L Snyder, Bryan R Meade, Cheryl C Saenz et al. |
|---|---|
| YEAR | 2004 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pbio.0020036